The Queen Elizabeth University Hospital is a 1,677-bed acute hospital located in Govan, in the south-west of Glasgow, Scotland. The hospital is built on the site of the former Southern General Hospital and opened at the end of April 2015.

During the past decade, Queen Elizabeth University Hospital conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 29 clinical trials were completed, i.e. on average, 21.2% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 25 clinical trials were completed. i.e. 41% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen Elizabeth University Hospital" #1 sponsor was "NHS Greater Glasgow and Clyde" with 21 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "University of Edinburgh" with 8 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored and "Celgene" with 6 trials sponsored. Other sponsors include 85 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth University Hospital" #1 collaborator was "University of Glasgow" with 15 trials as a collaborator, "NHS Greater Glasgow and Clyde" with 6 trials as a collaborator, "NHS Lothian" with 6 trials as a collaborator, "University of Edinburgh" with 4 trials as a collaborator and "Chief Scientist Office of the Scottish Government" with 3 trials as a collaborator. Other collaborators include 85 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Queen Elizabeth University Hospital" are "Crohn Disease" (8 trials), "Heart Failure" (6 trials), "Crohn's Disease" (5 trials), "Cardiovascular Diseases" (4 trials) and "Cystic Fibrosis" (4 trials). Many other conditions were trialed in "Queen Elizabeth University Hospital" in a lesser frequency.

Most popular intervention types in "Queen Elizabeth University Hospital" are "Drug" (82 trials), "Device" (18 trials), "Other" (18 trials), "Biological" (10 trials) and "Diagnostic Test" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Ocrelizumab" (5 trials), "Apixaban" (3 trials), "Deep Brain Stimulation (DBS)" (3 trials) and "Edoxaban" (3 trials). Other intervention names were less common.

The vast majority of trials in "Queen Elizabeth University Hospital" are 133 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 65 active trials in "Queen Elizabeth University Hospital". 1 are not yet recruiting, 41 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 44 completed trials in Queen Elizabeth University Hospital, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Queen Elizabeth University Hospital, 10 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 28 trials that are defined as “Not Applicable".